Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Pharm Res. 2014 Sep 11;32(3):986–1001. doi: 10.1007/s11095-014-1511-3

Table IV.

Comparison of QSAR results for test and training sets.

Fraction of Training Set Ligands with Rank Total Number of Active Ligands
QSAR Model Top 1 Top 2 Top 3
X-ray, training 0.76 0.88 1.00 33
X-ray, test 0.79 0.86 0.93 14
Pseudo-apo, training 0.88 1.00 1.00 51
Pseudo-apo, test 1.00 1.00 1.00 19